Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bd03 (1 trial)
Communicable Diseases (Phase 1)
Cytomegalovirus Infections (Phase 1)
Infections (Phase 1)
Virus Diseases (Phase 1)
Trials (1 total)
Trial APIs (1 total)